Gange SJ - Search Results

1

Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.

Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Hanna DB, et al. Among authors: gange sj. PLoS One. 2013 Nov 18;8(11):e78952. doi: 10.1371/journal.pone.0078952. eCollection 2013. PLoS One. 2013. PMID: 24260137 Free PMC article. Clinical Trial.

2

Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.

Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, Gange SJ; Women's Interagency HIV Study Collaborative Research Group. Kirstein LM, et al. Among authors: gange sj. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):495-503. doi: 10.1097/00126334-200204150-00010. J Acquir Immune Defic Syndr. 2002. PMID: 11981366

3

Serum albumin is a powerful predictor of survival among HIV-1-infected women.

Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, Williams C, Goldwasser P, Anastos K. Feldman JG, et al. Among authors: gange sj. J Acquir Immune Defic Syndr. 2003 May 1;33(1):66-73. doi: 10.1097/00126334-200305010-00010. J Acquir Immune Defic Syndr. 2003. PMID: 12792357

4

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.

Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Sethi AK, et al. Among authors: gange sj. Clin Infect Dis. 2003 Oct 15;37(8):1112-8. doi: 10.1086/378301. Epub 2003 Sep 19. Clin Infect Dis. 2003. PMID: 14523777

5

The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women.

Maurer T, Rodrigues LK, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, French AL, Glesby M, Jordan C, Khalsa A, Hessol NA. Maurer T, et al. Among authors: gange sj. Clin Infect Dis. 2004 Feb 15;38(4):579-84. doi: 10.1086/381264. Epub 2004 Jan 30. Clin Infect Dis. 2004. PMID: 14765353

6

The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.

Anastos K, Barrón Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, Young M, Gange SJ. Anastos K, et al. Among authors: gange sj. Ann Intern Med. 2004 Feb 17;140(4):256-64. doi: 10.7326/0003-4819-140-4-200402170-00007. Ann Intern Med. 2004. PMID: 14970148

7

Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy.

Barrón Y, Cole SR, Greenblatt RM, Cohen MH, Anastos K, DeHovitz JA, Delapenha R, Gange SJ. Barrón Y, et al. Among authors: gange sj. AIDS. 2004 Jul 23;18(11):1579-84. doi: 10.1097/01.aids.0000131359.37210.1f. AIDS. 2004. PMID: 15238776

8

Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.

Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, Gange SJ. Silverberg MJ, et al. Among authors: gange sj. Clin Infect Dis. 2004 Sep 1;39(5):717-24. doi: 10.1086/423181. Epub 2004 Aug 16. Clin Infect Dis. 2004. PMID: 15356788 Free PMC article.

9

Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy.

Chu JH, Gange SJ, Anastos K, Minkoff H, Cejtin H, Bacon M, Levine A, Greenblatt RM. Chu JH, et al. Among authors: gange sj. Am J Epidemiol. 2005 May 1;161(9):881-90. doi: 10.1093/aje/kwi116. Am J Epidemiol. 2005. PMID: 15840621

10

The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women.

Anastos K, Schneider MF, Gange SJ, Minkoff H, Greenblatt RM, Feldman J, Levine A, Delapenha R, Cohen M; Women's Interagency HIV Study Collaborative Group. Anastos K, et al. Among authors: gange sj. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):537-44. J Acquir Immune Defic Syndr. 2005. PMID: 16044004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page